BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ha1004

4+ PubMed studies analyzed · Evidence Score: 7.1

Research Domains

Ha1004 has been studied across 4 research domains including 🦴 Bone & Joint, 🔬 Oncology, 🧬 Hormones, 🫁 Respiratory. The primary research focus is 🦴 Bone & Joint with 50% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ha1004, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Harmine
2 shared targets
hydroxyfasudil
2 shared targets
pf
2 shared targets
alsterpaullone
2 shared targets
kenpaullone
2 shared targets
sp600125
3 shared targets
pf
2 shared targets
Sorafenib
2 shared targets
tae
2 shared targets
bufo
2 shared targets
Loading evidence profile...

This evidence profile for Ha1004 is generated deterministically from 4 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.